Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Has Average Target Price of $14.06 According to Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have received an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $14.06.

Several equities analysts have issued reports on the stock. Royal Bank Of Canada increased their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. Truist Financial raised their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, August 24th. BMO Capital Markets raised their price objective on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Raymond James Financial raised their target price on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a report on Friday, August 14th.

Aveanna Healthcare Stock Up 0.8%

AVAH stock opened at $12.44 on Tuesday. Aveanna Healthcare has a 52 week low of $5.93 and a 52 week high of $14.71. The firm has a 50 day moving average of $12.88 and a 200 day moving average of $9.61. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a market capitalization of $2.71 billion, a PE ratio of 10.11, a price-to-earnings-growth ratio of 0.76 and a beta of 1.95.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. Sell-side analysts forecast that Aveanna Healthcare will post 0.77 earnings per share for the current year.

Insider Activity at Aveanna Healthcare

In related news, major shareholder Paul R. Vigano sold 2,250,000 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This represents a 15.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the transaction, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 48,566,081 shares of company stock worth $558,509,932. 5.30% of the stock is currently owned by insiders.

Institutional Trading of Aveanna Healthcare

A number of hedge funds have recently made changes to their positions in the company. Littlejohn & Co. LLC purchased a new position in shares of Aveanna Healthcare during the 2nd quarter valued at approximately $1,846,878. Man Group plc acquired a new stake in shares of Aveanna Healthcare during the second quarter worth approximately $1,043,000. The Manufacturers Life Insurance Company bought a new stake in shares of Aveanna Healthcare in the second quarter worth $367,000. Parkman Healthcare Partners LLC acquired a new stake in Aveanna Healthcare in the second quarter valued at $6,123,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Aveanna Healthcare in the second quarter valued at $752,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna’s services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.